-+ 0.00%
-+ 0.00%
-+ 0.00%

RMTG’s Cellgenic launches NK cell product line for Latin America, Southeast Asia markets

PUBT·08/24/2026 11:04:14
Listen to the news
RMTG’s Cellgenic launches NK cell product line for Latin America, Southeast Asia markets
  • Regenerative Medical Technology Group launched an NK cell product line via Cellgenic for permitted markets outside the US.
  • Initial commercial focus targets Latin America and Southeast Asia to capture rising international demand for advanced cellular-technology offerings.
  • Move broadens the portfolio into immunology-adjacent categories, supporting cross-selling to physicians and clinics under local regulatory frameworks.
  • Strategy aims to turn existing sourcing and manufacturing capabilities into near-term revenue without building new facilities, improving capital efficiency.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608240701ACCESSWRNAPR_____1210940) on August 24, 2026, and is solely responsible for the information contained therein.